Jenny Jiang
About Jenny Jiang
Jenny Jiang is the Director at Bristol Myers Squibb with over 15 years of experience in health outcomes analysis and pharmaceutical economics.
Current Role at Bristol Myers Squibb
Jenny Jiang is currently serving as a Director at Bristol Myers Squibb. She has been with the company since 2018, steadily advancing from managerial roles to her current directorial position. Her vast experience and expertise in health outcomes analysis and pharmaceutical economics contribute significantly to her leadership in the company.
Career Progression at Walgreens
Jenny Jiang spent a notable 13 years at Walgreens, where she progressed from a Health Outcomes Analyst to a Senior Health Outcomes Analyst. Joining Walgreens in 2005, she initially worked as a Health Outcomes Analyst for two years before being promoted to a Senior Health Outcomes Analyst, a position she held for 11 years until 2018. Her extensive tenure at Walgreens has fortified her expertise in health outcomes analysis.
Bristol Myers Squibb Tenure
Since joining Bristol Myers Squibb in 2018, Jenny Jiang has held multiple roles at the Center for Observational Research & Data Sciences. Starting as a Manager and quickly transitioning to an Associate Director within six months, she continued to rise through the ranks and now holds the position of Director. Her rapid progression underscores her capability and expertise in the field.
Educational Background
Jenny Jiang holds a Doctor of Medicine (M.D.) from Shanghai Jiao Tong University, where she studied Internal Medicine and Radiology. Additionally, she achieved a Master’s degree in Pharmacoeconomics/Pharmaceutical Economics from The University of Georgia. Her educational background provides a strong foundation in both clinical and economic aspects of healthcare.
Expertise in Health Outcomes Analysis
With over 15 years of experience in health outcomes analysis and pharmaceutical economics, Jenny Jiang brings a wealth of knowledge to her roles. Her combined expertise in internal medicine and pharmacoeconomics positions her as a leader in the analysis and interpretation of health outcomes, making substantial contributions to her field.